MRNA · Insider Trading
Moderna, Inc. Common Stock
Every open-market purchase and sale reported by MRNA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-16 | Stephen Hoge | President | MIXED | +74,536 | −$15.15M |
| 2026-10-07 | James M Mock | Chief Financial Officer | MIXED | +750 | −$133.77K |
| 2026-09-16 | Stephen Hoge | President | MIXED | +72,330 | −$9.82M |
| 2026-09-14 | James M Mock | Chief Financial Officer | MIXED | −15,000 | −$4.07M |
| 2026-09-08 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | +6,093 | −$849.15K |
| 2026-09-08 | James M Mock | Chief Financial Officer | MIXED | +6,093 | −$849.15K |
| 2026-09-03 | James M Mock | Chief Financial Officer | MIXED | +1,278 | −$167.99K |
| 2026-09-03 | Stephen Hoge | President | MIXED | +4,794 | −$629.99K |
| 2026-09-03 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | +1,118 | −$525.38K |
| 2026-08-31 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | +568 | −$78.97K |
| 2026-08-31 | Stephen Hoge | President | MIXED | +1,057 | −$146.27K |
| 2026-08-31 | James M Mock | Chief Financial Officer | MIXED | +568 | −$78.97K |
| 2026-08-07 | Stephane Bancel | Chief Executive Officer | MIXED | +252,469 | −$14.32M |
| 2026-08-07 | Stephane Bancel | Chief Executive Officer | MIXED | +252,469 | −$14.32M |
| 2026-07-16 | Stephen Hoge | President | MIXED | — | −$2.58M |
| 2026-07-10 | Michael R. McDonnell | Director | A | +14,766 deriv. | — |
| 2026-07-07 | Soria Ester Banque | Chief Commercial Officer | A | +57,022 deriv. | — |
| 2026-07-06 | James M Mock | Chief Financial Officer | MIXED | +749 | −$50.97K |
| 2026-06-17 | Stephen Hoge | President | MIXED | — | −$1.72M |
| 2026-06-08 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | +6,093 | −$360.41K |
| 2026-06-08 | James M Mock | Chief Financial Officer | MIXED | +6,093 | −$294.32K |
| 2026-06-03 | Stephen Hoge | President | MIXED | +4,794 | −$211.79K |
| 2026-06-03 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | +1,118 | −$49.41K |
| 2026-06-03 | James M Mock | Chief Financial Officer | MIXED | +1,278 | −$56.49K |
| 2026-05-29 | Stephen Hoge | President | MIXED | +1,057 | −$46.73K |
| 2026-05-29 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | +568 | −$25.16K |
| 2026-05-29 | James M Mock | Chief Financial Officer | MIXED | +568 | −$25.16K |
| 2026-05-22 | Noubar Afeyan | Director | MIXED | — | −$256.49K |
| 2026-05-18 | Stephen Hoge | President | MIXED | — | −$1.56M |
| 2026-05-08 | Noubar Afeyan | Director | A | +12,908 deriv. | — |
| 2026-05-08 | Elizabeth E Tallett | Director | A | +8,371 deriv. | — |
| 2026-05-08 | Francois Nader | Director | A | +10,639 deriv. | — |
| 2026-05-08 | Elizabeth G Nabel | Director | A | +8,371 deriv. | — |
| 2026-05-08 | Sandra Horning | Director | A | +11,773 deriv. | — |
| 2026-05-08 | Abbas Hussain | Director | A | +8,371 deriv. | — |
| 2026-05-08 | David M. Rubenstein | Director | A | +11,773 deriv. | — |
| 2026-05-04 | Elizabeth E Tallett | Director | M | +4,058 | — |
| 2026-05-04 | Francois Nader | Director | M | +12,174 | — |
| 2026-05-04 | Elizabeth G Nabel | Director | M | +16,233 | — |
| 2026-05-04 | Abbas Hussain | Director | MIXED | +10,551 | −$264.95K |
| 2026-05-04 | David M. Rubenstein | Director | M | +8,116 | — |
| 2026-05-04 | Sandra Horning | Director | M | +16,233 | — |
| 2026-04-06 | James M Mock | Chief Financial Officer | MIXED | +750 | −$35.17K |
| 2026-03-06 | James M Mock | Chief Financial Officer | MIXED | +6,093 | −$329.69K |
| 2026-03-06 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | +6,093 | −$329.69K |
| 2026-03-03 | James M Mock | Chief Financial Officer | MIXED | +5,681 | −$275.25K |
| 2026-03-03 | Shannon Thyme Klinger | Chief Legal Officer | MIXED | +5,162 | −$546.29K |
| 2026-03-03 | Stephen Hoge | President | MIXED | +20,570 | −$995.93K |
| 2026-03-03 | Stephane Bancel | Chief Executive Officer | A | — | — |
| 2026-02-25 | Stephen Hoge | President | MIXED | — | −$4.75M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Stephane Bancel | Chief Executive Officer | 12,939,715 | $2.94B |
| Noubar Afeyan | Director | 2,971,912 | $674.30M |
| Stephen Hoge | President | 1,679,826 | $381.14M |
| Paul Sagan | Director | 312,730 | $70.96M |
| Shannon Thyme Klinger | Chief Legal Officer | 87,044 | $19.75M |
| James M Mock | Chief Financial Officer | 60,125 | $13.64M |
| Francois Nader | Director | 32,781 | $7.44M |
| Elizabeth G Nabel | Director | 19,317 | $4.38M |
| Sandra Horning | Director | 18,585 | $4.22M |
| Abbas Hussain | Director | 17,748 | $4.03M |
| David M. Rubenstein | Director | 9,643 | $2.19M |
| Elizabeth E Tallett | Director | 4,761 | $1.08M |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MRNA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.